Page last updated: 2024-10-26

dipyridamole and Amyloid Angiopathy, Cerebral

dipyridamole has been researched along with Amyloid Angiopathy, Cerebral in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research Excerpts

Excerpt	Relevance	Reference
"Dipyridamole treatment did not worsen frequency and size of cerebral microscopic bleeding."	1.37	Therapeutic modulation of cerebral microhemorrhage in a mouse model of cerebral amyloid angiopathy. ( Cribbs, DH; Fisher, M; Passos, GF; Quiring, D; Vasilevko, V; Ventura, C, 2011)

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fisher, M	1
Vasilevko, V	1
Passos, GF	1
Ventura, C	1
Quiring, D	1
Cribbs, DH	1

Clinical Trials (1)

Trial Overview

Trial			Phase	Enrollment	Study Type	Start Date	Status
Non-invasive Evaluation of Cerebrovascular Reactivity in Spontaneous Intracerebral Hemorrhage[NCT03815513]			Phase 1	60 participants (Anticipated)	Interventional	2019-01-21	Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for dipyridamole and Amyloid Angiopathy, Cerebral

Article	Year
Therapeutic modulation of cerebral microhemorrhage in a mouse model of cerebral amyloid angiopathy. Stroke, 2011, Volume: 42, Issue:11 Topics: Animals; Cerebral Amyloid Angiopathy; Cerebral Hemorrhage; Dipyridamole; Disease Models, Animal; Fem	2011